Choice Source Therapeutics
Caremark Rx, Inc. (NYSE: CMX) reported today that it completed the acquisition of Choice Source Therapeutics, Inc., a specialty distribution business with a primary focus on providing pharmacy and clinical services for people with hemophilia, for $48.5 million in cash.